Decide what to file. Decide what to ship.
Patenter analyzes life-science invention disclosures and product designs against the prior art and FTO landscape — surfacing novelty risk, blocking patents, and commercial fit across biotech, medical devices, diagnostics, and pharma. Built for technology transfer offices, corporate IP teams, and outside counsel.
Most disclosures aren't worth filing. Most products are safe to ship. The hard part is knowing which.
A typical TTO files 30–40% of the disclosures it receives. A typical corporate IP team ships 90%+ of products without infringement issues. But the cost of getting it wrong on either side — a wasted $25K filing, a $50M lawsuit — makes triage the most expensive decision in IP.
Patenter is built to make that decision faster, more rigorous, and traceable.
Element-by-element novelty analysis under §102 and §103.
Comprehensive prior art search across patent and non-patent literature. Element-by-element claim mapping under §102 and §103. Risk posture dial (conservative / moderate / aggressive) lets you calibrate the threshold to your filing strategy.
FTO clearance grounded in claim elements.
Element-level mapping of your embodiments against third-party claims. Clearance status (Clear / Caution / Risky / Blocked) with confidence levels. Surfaces blocking patents, expiration dates, and IPR windows so you know exactly what stands between your product and the market.
Market sizing, TRL, and licensee discovery.
TAM/SAM estimates that drive the licensing-vs-spinout decision. TRL assessment to calibrate commercialization pathway. Matched-company search surfaces strategic and tactical buyers for each asset.
Different users. Different lenses. Same evidence base.
Triage 80 disclosures with the rigor you'd give 10.
Licensing officers see more disclosures than they can deeply evaluate. Patenter is your triage engine — surfacing the 30–40% that justify filing investment, with audit-grade backup when you need to defend the decision to faculty or the VP of Research.
- →AI-assisted inventor interviews fix the #1 bottleneck: incomplete disclosures from faculty
- →Novelty Signal View — the 5-minute read for licensing officers managing 50–80 disclosures
- →Recommendations surface next steps for each disclosure: follow-up with inventor, send to counsel, file provisional
- →Counsel Export Package cuts outside counsel filing prep hours significantly
- →Inventor Brief View tells faculty which features carry novelty before they publish
From disclosure to filing decision in five steps.
Working with organizations leading the way in commercialization.
Patenter partners with consortia and federal innovation programs to accelerate the path from discovery to deployment.
MTEC is a DoD-focused nonprofit that funds medical technology development.
A military- and medical-connected community empowering MedTech, Biotech, and Pharma companies with access to Operational and Clinical subject matter experts, non-dilutive DoD/Federal R&D funding, and commercialization resources.
Per-project to start. Per-portfolio when you scale.
For inventors and small teams running a one-off filing decision. First project free.
- ✓Full novelty analysis
- ✓FTO clearance
- ✓Market sizing + matched companies
- ✓Counsel export package
- ✓PDF and structured exports
For technology transfer offices and corporate IP teams managing portfolios. Volume pricing on disclosures, shared workspace, and audit-grade exports for board and counsel handoff.
- ✓Everything in Single project
- ✓Portfolio dashboard with recommendations
- ✓Multi-user team workspace
- ✓Inventor Brief + Executive Report views
- ✓SSO, audit logs, dedicated support